SUPERMAN PROTOCOL

$229.00 AUD

Sale Sold out

Shipping calculated at checkout.

Bundle Single Protocol 3 Protocol Bundle 5 Protocol Bundle

COMPOUNDS INCLUDED

2 x 10mg vial

IPAMORELIN
CJC-1295 (NO DAC)

View full details

COMPOUND OVERVIEW

A structured breakdown of the compounds within the SUPERMAN protocol, designed around growth hormone signalling, recovery support, and elevated performance-focused restoration pathways.

COMPOUND 01

CJC-1295 (NO DAC)

CJC-1295 (no DAC) is a synthetic peptide analogue referenced in research for its association with growth hormone signalling, recovery frameworks, and performance-support pathways. Within the SUPERMAN protocol, it forms the foundational signalling component designed to support elevated recovery and regenerative output.

GH signalling Recovery framework Performance support

COMPOUND 02

IPAMORELIN

Ipamorelin is a selective peptide studied for its association with pulsatile growth hormone release, recovery optimisation, and tissue-support models. In this protocol, it complements CJC-1295 by reinforcing the signalling environment while maintaining a clean, focused performance and recovery profile.

GH pulse support Recovery optimisation Selective signalling

PROTOCOL ARCHITECTURE

The SUPERMAN protocol is structured as a two-part signalling system. CJC-1295 establishes the broader growth hormone releasing framework, while Ipamorelin supports a more selective pulse-based response. Together, they create a streamlined protocol designed around recovery continuity, tissue support, and elevated performance-oriented signalling.

CJC-1295 Foundational GH signalling support

IPAMORELIN Selective pulse amplification

SUPERMAN PROTOCOL